{
    "Trade/Device Name(s)": [
        "MicroScan MICroSTREP plus Panels with Tetracycline (0.06-16 \u03bcg/mL)"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K202423",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020939",
        "K062923"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY",
        "LTT",
        "LRG",
        "JTZ",
        "LTW"
    ],
    "Summary Letter Date": "August 12, 2020",
    "Summary Letter Received Date": "August 25, 2020",
    "Submission Date": "August 12, 2020",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tetracycline"
    ],
    "Specimen Type(s)": [
        "Aerobic Streptococci colonies",
        "Streptococcus pneumoniae colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Manual reading",
        "Automated reading"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration (MIC) determination",
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panels with Tetracycline for antimicrobial susceptibility testing of Streptococcus species.",
    "Indications for Use Summary": "Used to determine antimicrobial agent susceptibility of Streptococcus spp. and Streptococcus pneumoniae, including quantitative/qualitative MIC of tetracycline (0.06-16 \u03bcg/mL), read manually or by MicroScan WalkAway instrument.",
    "fda_folder": "Microbiology"
}